Viewing Study NCT01200420


Ignite Creation Date: 2025-12-25 @ 4:14 AM
Ignite Modification Date: 2026-01-13 @ 5:17 PM
Study NCT ID: NCT01200420
Status: COMPLETED
Last Update Posted: 2012-01-31
First Post: 2010-09-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Multiple Ascending Dose Study of Miravirsen in Treatment-Naïve Chronic Hepatitis C Subjects
Sponsor: Santaris Pharma A/S
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hepatitis C View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Antisense View
None miR-122 antagonist View
None host factor View
None CHC View